Atlas Trials

AltruBio Inc.

5 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch AltruBio Inc.

RecordFirmDate
Evaluate the Safety, Tolerability, PK and PD of SAD of Intravenously Adminsterted ALTB-268 in Healthy Participants (NCT07350577)AltruBio Inc.2025-11-17
Efficacy/Safety of ALTB-268 in Subjects w/Moderately to Severely Active UC Refractory to Biologics (NCT06109441)AltruBio Inc.2023-12-04
A First-In-Human SAD and MAD Study to Evaluate the Safety, Tolerability, PK and PD of SC Administered ALTB-268 in Healthy Volunteers (NCT05723692)AltruBio Inc.2023-01-17
Neihulizumab (ALTB-168) in Patients With Steroid-refractory Acute Graft-versus-host Disease or Treatment-refractory Acute Graft-versus-host Disease (NCT03327857)AltruBio Inc.2018-05-31
Efficacy&Safety of ALTB-168 in Patients With Moderate to Severe Active,Anti-TNF Alpha and/or Anti-integrin Refractory UC (NCT03298022)AltruBio Inc.2018-05-04

Track AltruBio Inc. automatically

Every clearance here is in the API, with alerts when new ones post.